Pharmafile Logo
Pharmafocus logo
Advanced Search

The future for pharma packaging

March 1, 2016
Manufacturing and Production distribution, packaging, research, supply chain

The pharmaceutical packaging market is projected for strong growth through 2020, driven by innovation for new products and materials and …

Feature
lupin_pharma_logo

Lupin to set up manufacturing plant in Japan

March 1, 2016
Manufacturing and Production Japan, Lupin, manufacturing

Indian drugmaker Lupin is, via its Japanese unit Kyowa, setting up a manufacturing unit in Japan as part of its …

News
alzheimers

South Florida Uni begins £875,000 dementia drug research programme

March 1, 2016
Manufacturing and Production, Research and Development Alzheimer's

Funding from a consortium worth £875,000 pounds has helped kick start a new dementia drug research program at the University …

News
astellas

Japan approves Astellas hyperphosphatemia drug

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Hyperphosphatemia, Japan, Kiklin

Astellas Pharma has received approval from the Ministry of Health, Labour and Welfare in Japan for a supplemental new drug …

News
valeant_logo_on_board

Valeant shares slide on SEC investigation announcement

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Philidore, Valeant, regulation

Shares at troubled Valeant plummeted some 20% Monday after the company said it was under investigation by the Securities and …

News

AstraZeneca licenses European rights to constipation drug for $70m

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, EU, Japan, Luke Miles, ProStrakan Group, constipation drug, moventig

AstraZeneca said on Tuesday it has agreed to licence rights to its constipation drug Moventig to Japan’s ProStrakan Group for …

News
astrazeneca_plaque

AstraZeneca announces tremelimumab setback in mesothelioma test

March 1, 2016
Manufacturing and Production, Research and Development AstraZeneca, Cancer, MedImmune, tremelimumab

AstraZeneca and its global biologics research and development arm, MedImmune, have announced a setback in the result of their Phase …

News
gensight

GenSight begins Phase III retinal disease trials

February 29, 2016
Research and Development GenSight, Leber’s Hereditary Optic Neuropathy, retinal disease

French biotech GenSight has begun enrolling patients for two parallel pivotal Phase III trials with its lead candidate GS010, a …

News
eli_lilly

CHMP recommends Lilly psoriasis drug for approval

February 29, 2016
Research and Development Eli Lilly, Taltz, psoriasis

Eli Lilly’s Taltz (ixekizumab) has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for …

News
roche_good

Roche finds contradictory results in identical Phase III asthma trials

February 29, 2016
Manufacturing and Production, Research and Development Roche, lebrikizumab asthma

Roche has reported contradictory results from two identical Phase III studies of lebrikizumab in severe asthma, with one showing the …

News
ucb_logo

New epilepsy drug launches in UK

February 29, 2016
Medical Communications, Research and Development, Sales and Marketing Briviact, UCB Pharma, epilepsy

UCB Pharma’s Briviact (brivaracetam) has been authorised as an add-on treatment for partial onset seizures (POS), with or without secondary …

News
roche_glass_building

FDA approves Roche’s Gazyva in follicular lymphoma

February 29, 2016
Research and Development, Sales and Marketing Levact, MabThera

Strong Phase III results have seen the US FDA approve Roche’s Gazyva (obinutuzumab) plus Levact (bendamustine) chemotherapy followed by Gazyva …

News
findacure

Drug repurposing can help tackle Rare Diseases, says charity

February 29, 2016
Medical Communications, Research and Development, Sales and Marketing rare diseases

On Rare Disease Day 2016, UK charity Findacure says existing drugs may hold the key to new treatments and repurposing …

News
boehringer_good

Boehringer launches IPF initiatives

February 29, 2016
Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Esbriet, Roche, idiopathic pulmonary fibrosis, ofev

Boehringer Ingelheim has launched a collaborative initiative aimed at raising awareness and understanding of the rare lung disease Idiopathic Pulmonary …

News
afinitor

FDA approves new indication for Novartis’ Afinitor

February 29, 2016
Research and Development, Sales and Marketing Afinitor, Novartis

Novartis’ cancer drug Afinitor (everolimus) has been granted FDA approval in a new indication: for the treatment of adult patients …

News
eisai_logo

Eisai slams new Cancer Drugs Fund for delaying patient access

February 26, 2016
Research and Development, Sales and Marketing Cancer Drugs Fund, Eisai, Lenvima

Eisai has aimed strong criticism at NHS England for its approval of reforms to the Cancer Drugs Fund, calling the …

News
gilead-sciences

Positive CHMP opinion for Gilead’s Descovy

February 26, 2016
Research and Development Gilead Sciences

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has adopted a positive opinion …

News
boehringer_good

Boehringer’s OFEV slows IPF disease progression by half in trials

February 26, 2016
Research and Development, Sales and Marketing Boehringer Ingelheim, IPF, ofev

Boehringer Ingelheim has revealed pooled analysis data from three trials, showing that its drug OFEV significantly reduces the risk of …

News

INTERVIEW: AstraZeneca on the Cancer Drugs Fund reforms

February 26, 2016
Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund

Greg Rossi, head of the Oncology Business Unit, AstraZeneca UK and Ireland, and the company’s market access team, spoke to …

Feature
baumann_bayer

Bayer names Werner Baumann new CEO

February 26, 2016
Medical Communications Bayer

Werner Baumann will become the new chief executive of Bayer AG from May 1, the company has announced. The decision …

Appointment
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026